Please join MSCI for a one-hour webinar on Thursday, May 20, featuring Dr. Mark McClellan. This webinar is Dr. McClellan’s second with MSCI. Our first was an early January discussion about the then-new COVID vaccine rollout. We’re now far into the rollout, and the issues and challenges ahead are very different. This time we’ll have a conversation about what we face in the coming months as the economy reopens and possible future pandemics. How can we build a better infrastructure for health care, therapeutic medications, prevention strategies, protective equipment, and yes, new vaccines? What have we learned from our COVID-19 experiences that can make us stronger, better able to handle these problems in the future?

Speaker: Mark McClellan, MD, PhD

Mark McClellan, MD, PhD, is Director and Robert J. Margolis, M.D., Professor of Business, Medicine and Policy at the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence and more effective drug and device innovation. Dr. McClellan is at the center of the nation’s efforts to combat the pandemic and the author of a roadmap that details the steps needed for a comprehensive COVID-19 response and safe reopening of our country. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. Dr. McClellan is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and serves as an advisor for Arsenal Capital Group, Blackstone Life Sciences, and MITRE.